AI assistant
CervoMed Inc. — Director's Dealing 2024
Jan 26, 2024
34364_dirs_2024-01-26_d7084ddf-a9b0-44b1-8f1c-1710229e9bc1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CervoMed Inc. (CRVO)
CIK: 0001053691
Period of Report: 2024-01-26
Reporting Person: Gregoire Sylvie (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-26 | Stock Option (Right to Buy) | $9.05 | A | 35500 | Acquired | 2034-01-26 | Common Stock (35500) | Indirect |
Footnotes
F1: Consists of an option to purchase shares of common stock granted to John Alam, M.D., the Reporting Person's spouse and the Chief Executive Officer of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2: The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024.